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Members of the genus Lathyrus are used as food and as traditional medicines. In order
to find new sources of biologically-active compounds, chemical and biological profiles
of two Lathyrus species (L. czeczottianus and L. nissolia) were investigated. Chemical
profiles were evaluated by HPLC-ESI-MSn, as well as by their total phenolic and flavonoid
contents. In addition, antioxidant, enzyme inhibitory, and cytotoxic effects were also
investigated. Antioxidant properties were tested by using different assays (DPPH, ABTS,
CUPRAC, FRAP, phosphomolybdenum, and metal chelation). Cholinesterases (AChE
and BChE), tyrosinase, α-amylase, and α-glucosidase were used to evaluate enzyme
inhibitory effects. Moreover, vitexin (apigenin-8-C-glucoside) and 5-O-caffeoylquinic acid
were further subjected to molecular docking experiments to provide insights about
their interactions at molecular level with the tested enzymes. In vitro cytotoxic effects
were examined against human embryonic kidney cells (HEK293) by using iCELLigence
real time cell analysis system. Generally, L. czeczottianus exhibited stronger antioxidant
properties than L. nissolia. However, L. nissolia had remarkable enzyme inhibitory effects
against cholinesterase, amylase and glucosidase. HPLC-ESI-MSn analysis revealed that
flavonoids were major components in these extracts. On the basis of these results,
Lathyrus extracts were rich in biologically active components; thus, these species could
be utilized to design new phytopharmaceutical and nutraceutical formulations.
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INTRODUCTION
With recent advances in science, the therapeutic properties
of plants have gained importance all over the world, due to
their pharmacological activities (antioxidant, anti-cancer, anti-
inflammatory, antimicrobials, etc.) and nutraceuticals properties
(Krishnaiah et al., 2011). Many reports have focused on benefits
of phytochemicals from plants and their health-promoting
effects. Among the various phytochemicals with biological
properties, phenolic compounds are responsible for the above-
mentioned biological activities (Shahidi and Ambigaipalan,
2015). Actually, in global communities increasingly concerned
on health and nutrition, these products are emerging as valuable
alternatives for replacing synthetic drugs. On the basis of
the aforementioned concerns, new plant-derived products or
phytomedicines are considered as prospective materials.
The genus Lathyrus, which belongs to Fabaceae, is represented
by more than 200 species worldwide (Alkin et al., 1986). This
genus consists of 75 taxa, of which 18 species are endemic in
Turkish Flora (Genç, 2009). Like most members of Fabaceae,
Lathyrus genus presents different uses, such as alimentary,
agricultural, industrial, ornamental, and in traditional medicine
(Patto and Rubiales, 2014). For instance, some Lathyrus species
such as L. hirsutus L., L. cicera L., L. odoratus L., L. ochrus
L. (DC.), L. sylvestris L., and L. palustris L., which have high
nutrient quality, are consumed as food (for both humans
and animals) (Chavan et al., 2001). Especially, roots of L.
odoratus are used as food in The East Anatolian Region of
Turkey. Again, L. odoratus and L. sativus L. are used for
agricultural processes in Turkey. Moreover, Lathyrus species have
also importance in folk medicine for several purposes such as
analgesic (seed of L. sativus), anti-inflammatory (aerial parts of
L. cicera), and anti-rheumatism (leaf of L. rotundifolius Willd.
subsp. miniatus (Bieb. ex Stev.) Davis) in Turkey (Altundag
and Ozturk, 2011). However, up-to-date information about L.
czeczottianus Bässler and L. nissolia L. chemical composition or
biological characterization is scarce. Considering the importance
of different Lathyrus species, as previouslymentioned, the general
aim of this research is to improve the knowledge about less-
known Lathyrus plants. In this direction, this study was designed
to investigate: (i) the antioxidant activity of the methanolic
extracts of L. czeczottianus and L. nissolia using various in
vitro biochemical assays, (ii) the enzyme inhibitory potentials
(anti-cholinesterase, anti-amylase, anti-glucosidase, and anti-
tyrosinase), (iii) the cytotoxicity in human embryonic kidney
cells using the real time cellular impedance technology, (iv) the
characterization of phytochemical compounds in the methanolic
extracts by HPLC-ESI-MS, (v) and the components-enzymes
interactions with in-silico techniques. Thus, our present study
may contribute to offer new perspectives on the biological
properties and phytochemical profile of the genus Lathyrus.
EXPERIMENTAL
Chemicals and Reagents
All reagents and standards were of analytical reagent grade
unless stated otherwise. Kaempferol (≥97%), luteolin (≥98%),
quercetin (≥95%) and rutin (≥95%) were purchased from Sigma-
Aldrich (St. Louis, MO, USA) and 200mg/L stock solutions
were prepared in ethanol (HPLC grade; Sigma). LC–MS grade
acetonitrile (CH3CN, 99%) (LabScan; Dublin, Ireland) and
ultrapure water (Milli-Q Waters purification system; Millipore;
Milford, MA, USA) were used for the HPLC-MS analyses.. Folin–
Ciocalteu’s reagent and methanol were purchased from Merck
(Darmstadt, Germany). 2,2-Diphenyl-1-picrylhydrazyl (DPPH),
ABTS radical cation (2,2′-azino-bis(3-ethylbenzothiazoline)-
6-sulphonic acid), DTNB (5,5-dithio-bis(2-nitrobenzoic) acid)
and AChE (acetylcholinesterase (Electric ell acetylcholinesterase,
Type-VI-S, EC 3.1.1.7), BChE (butyrylcholinesterase (horse
serum butyrylcholinesterase, EC 3.1.1.8), L-DOPA (3,4-
dihydroxy-L-phenylalanine), tyrosinase, acetylthiocholine iodide
(ATCI) and butyrylthiocholine chloride (BTCl) were purchased
from Sigma Chemical Co. All other chemicals and solvents were
of analytical grade.
Plant Material and Extraction Procedure
Lathyrus species were collected at flowering stage and
corresponding information and localities are explained below.
Taxonomic identification of the plant materials was confirmed by
senior taxonomist Dr. Murad Aydın Sanda [Selcuk University,
Science Faculty, Department of Biology (Botany)] based on Flora
of Turkey (Davis, 1970) and A checklist of the Flora of Turkey
(Vascular Plants) (Güner et al., 2012). Voucher specimens were
deposited at the KNYA Herbarium of Department of Biology,
Selcuk University, Konya-Turkey.
1. Lathyrus czeczottianus Bässler: Locality: Ankara, Cubuk,
around Karagol, forest clearings, Turkey. Date: 25/06/2013.
Collector: Ramazan Ceylan and Gokhan Zengin. Life cycle
stage of the plant: flowering. Plant part: aerial parts. Family:
Fabaceae.
2. Lathyrus nissolia L.: Locality: Ankara, Cubuk, around
Karagol, forest clearings, Turkey. Date: 13/06/2013. Collector:
Ramazan Ceylan and Gokhan Zengin. Life cycle stage of the
plant: flowering. Plant part: aerial parts. Family: Fabaceae.
The plant materials were dried at room temperature. The dried
aerial parts were ground to a fine powder using a laboratory mill.
To obtain methanolic extracts, the air-dried aerial parts (10 g)
were macerated with 200mL of methanol at room temperature
(25◦C ± 1◦C) for 24 h. The extracts were concentrated under
vacuum at 40◦C by using a rotary evaporator and stored at+ 4◦C
in dark until use.
Chromatographic Conditions
The HPLC system consisted of a vacuum degasser, an
autosampler and a binary pump (Agilent Series 1100, Agilent
Technologies, Santa Clara, CA, USA) equipped with a reversed
phase Kinetex core-shell C18 analytical column of 50 × 2.1mm
and 2.6 µm particle size (Phenomenex, Torrance, CA, USA). A
C18 Security Guard Ultra cartridge (Phenomenex) of 2.1mm i.d.
was placed before the analytical column. The best separation was
achieved by using a mobile phase consisting of acetonitrile (A)
and water-formic acid (100:0.1, v/v) (B). The following gradient
program was used: 10% A (0min), 25% A (10–20min), 50% A
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(40min), 100% A (42–47min), and 10% A (49min). The mobile
phase flow rate was 0.4mL min−1. After filtration through 0.45
µm PTFE membrane filters, 10 µL of each extract was injected.
The HPLC system was connected to an ion trap mass
spectrometer (Esquire 6,000, Bruker Daltonics, Billerica, MA,
USA) equipped with an electrospray interface operating in
negative ion mode. The scan range was set at m/z 100–1200 with
a speed of 13,000 Da/s. The ESI conditions were as follows: drying
gas (N2) flow rate and temperature, 10mL/min and 365◦C;
nebulizer gas (N2) pressure, 50 psi; capillary voltage, 4,500 V;
capillary exit voltage, −117.3 V. The acquisition of MSn data
was made in auto MSn mode, with isolation width of 4.0m/z,
and fragmentation amplitude of 0.6 V (MSn up to MS4). Esquire
control software was used for the data acquisition and Data
Analysis for processing.
Antioxidant and Enzyme Inhibitory Assays
The total phenolic content was determined by Folin-Ciocâlteu
method and expressed as gallic acid equivalents (GAEs/g
extract), while total flavonoid content was determined by AlCl3
method and expressed as rutin equivalents (REs/g extract) (Vlase
et al., 2014; Zengin et al., 2016). The antioxidant capacity
was investigated by different assays: radical scavenging assays
(DPPH and ABTS), reducing power (CUPRAC and FRAP),
phosphomolybdenum, and metal chelating (ferrozine method)
(Dezsi et al., 2015; Toma et al., 2015; Mocan et al., 2017).
Enzyme inhibitory activities were detected against cholinesterase,
α-amylase and α-glucosidase in 96-well plates. The experimental
procedures for antioxidant and enzyme inhibitory assays were
previously described by Mocan et al. (2016b) and Zengin et al.
(2016). The antioxidant and enzyme inhibitory effects were
evaluated by IC50 (%50 of free radical/ enzyme inhibition) and
EC50 (the effective concentration at which the absorbance was
0.5 in CUPRAC, FRAP and phosphomolybdenum assays) values.
The extracts were evaluated at 0.5–5 mg/mL in the antioxidant
and enzyme inhibitory assays. Trolox (0.05–0.5 mg/mL), EDTA
(0.01–0.04 mg/mL), galantamine (1–5 µg/mL), kojic acid (0.1–
0.4 mg/mL) and acarbose (1–4 mg/mL) were used as positive
controls in these assays. The calibration curves were used to
calculate IC50 and EC50 values for each extract and reference
compounds.
Molecular Modeling
Receptors Preparation
All the crystallographic enzyme structures have been downloaded
from the Protein Databank RCSB PDB (Berman et al., 2000):
acetylcholinesterase (pdb:4X3C) (Pesaresi and Lamba)
in complex with tacrine-nicotinamide hybrid inhibitor,
butyrilcholinesterase (pdb:4BDS) (Nachon et al., 2013) in
complex with tacrine, amylase (pdb:1VAH) (Zhuo et al., 2004)
in complex with r-nitrophenyl-α-D-maltoside, glucosidase
(pdb:3AXI) (Yamamoto et al., 2011) in complex with maltose,
and tyrosinase (pdb:2Y9X) (Ismaya et al., 2011) in complex
with tropolone. Waters, inhibitors and all the other molecules
present in the pdb files were removed by using Pymol (DeLano,
2002) and the proteins alone were neutralized at pH 7.4 by Epik
suit implemented in Maestro 9.2 suite (Maestro, 2011). Seleno-
cysteines and seleno-methionines, if present, were converted
respectively to cysteines and methionines. All the missing
fragments and other errors present in the crystal structures
were automatically solved by the Wizard Protein Preparation
implemented in Maestro 9.2 suite (Maestro, 2011).
Ligands Preparation
5-O-caffeoylquinic acid (5-O-CQA, compound 4), isoschaftoside
(compound 22) and vitexin (compound 33) were selected
as representative compounds to carry out molecular docking
studies, as these compounds were present in L. czeczottianus
and L. nissolia extracts. The chemical structures, reported in
Scheme 1, have been downloaded from Zinc databases (Irwin
et al., 2012) and used for molecular modeling experiments. The
ligands were prepared by the LigPrep tool embedded in Maestro
9.2, neutralized at pH 7.4 by Epik and minimized (Shelley et al.,
2007).
Molecular Docking
Dockings of vitexin (33), isoschaftoside (22) and 5-O-CQA (4)
have been performed for each selected enzyme employed for the
in vitro enzymatic inhibition tests in this work. Glide (Friesner
et al., 2006) has been employed for the docking calculations
SCHEME 1 | Chemical structures of compounds Vitexin,
Isoschaftoside, and 5-O-caffeoylquinic acid employed for docking
experiments.
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by using all the eXtra Precision scoring function for all the
enzymes, with the exception of the docking to tyrosinase; in this
case, Gold 6.0 (Jones et al., 1997) was used with the scoring
function Gold Score, which has been previously found to be
more suitable to produce reliable poses on metal containing
enzymes (Mocan et al., 2016b). In both cases, the binding pocket
was determined automatically by centering the grid on the
crystallographic inhibitor, extended in a radius of 10 Angstroms
from the center. The best pose for each compound docked to the
selected enzymes was the best ranked among the 200 generated.
Cytotoxicity Assay
Cell Culture
Human embryonic kidney cells (HEK-293) were obtained from
Leibniz-Institute DSMZ (German Collection of Microorganisms
and Cell Cultures, Braunschweig, Germany) and were cultured
in Dulbecco’s Modified Eagle’s Medium (DMEM) (Lonza, Basel,
Switzerland) containing 10% heat inactivated fetal bovine serum,
1% penicillin/streptomycin 100U mL−1 and 1% L-glutamine
200mM. Cells were maintained at 37◦C in a humidified
atmosphere of 5% CO2.
Cytotoxicity Assay with the iCELLigence System
Cytotoxic activity was performed by using the iCELLigence
real time cell analysis technology (RTCA) (ACEA Biosciences,
San Diego, CA, USA) as described previously (Lazarova et al.,
2015). In brief, HEK-293 cells were seeded in E-Plate L8 at a
density of 5 × 104 cells/well in 300 µL of growth medium.
The system was set to take measurements every 30min for 72 h.
After 24 h, when the cells were in exponential phase, they were
treated with 300 µL medium containing 2,000, 1,000, 500, 250,
125, 62.5 µg/mL of L. czeczottianus or L. nissolia methanolic
extracts prepared in DMEM containing 0.1% dimethyl sulfoxide
(DMSO). Cells were treated with 0.1% of DMSO as negative
control and 5% DMSO as positive control in all experiments.
Data analysis was performed using RTCA iCELLigence software
and IC50 values (µL/mL) were automatically calculated based on
the final readings obtained at the 72 h time point. All experiments
were repeated three times.
Morphological Evaluation of the Cells
Cells were plated at a density of 5 × 105 cells/well in 6-
well plate with 2 mL growth medium. Twenty-four hours after
seeding, the medium was removed and replaced with a medium
containing 500 µg/mL L. czeczottianus and 1,000 µg/mL L.
nissoliamethanolic extracts, which are close to IC50 values. After
72 h, the cells were washed with 1X phosphate buffered saline
(PBS) to remove cellular debris and photographed under an
inverted microscope Leica DM IL LED using a DFC-290 camera
(Leica, Wetzlar, Germany).
Statistical Analysis
For all the experiments, the assays were carried out in triplicate.
The results are expressed as mean values and standard deviation
(SD). The differences between the different extracts were
analyzed using one-way analysis of variance (ANOVA) followed
by Tukey’s honestly significant difference post-hoc test with α =
0.05. This treatment was carried out using SPSS v. 14.0 program.
RESULTS AND DISCUSSION
HPLC-ESI-MSn
The analysis of the phenolic composition in aerial parts of
L. czeczottianus and L. nissolia was performed by HPLC-ESI-
MSn using the negative ionization mode. Two independent
assays were carried out for each sample, obtaining similar data
regarding the nature and relative intensities of the detected
fragments. The base peak chromatograms of the methanolic
extracts are shown in Figure 1.
The initial step for the characterization of the phenolic
compounds consisted in the determination of the molecular
weight of each compound. In the negative ionization mode
(ESI−) MS1 spectrum, the most intense peak usually
corresponded to the deprotonated molecular ion [M-H]−.
Compounds were numbered in both chromatograms by their
order of elution. The tentative characterization of the detected
compounds is shown in Table 1, and the discussion of the
characterization is explained in the following sub-sections.
Phenolic Acids
Compound 3 exhibited the deprotonated molecular ion at
m/z 315, and suffered the neutral loss of 162 Da (hexoside)
to yield a fragment ion at m/z 153. It was characterized as
dihydroxybenzoic acid hexoside (Engels et al., 2012).
Four caffeoylquinic acids were detected in the analyzed
extracts. Compound 4, with [M-H]− at m/z 353, base peak ion
at m/z 191, and low intensity at m/z 179, was characterized as
5-caffeoylquinic acid (Clifford et al., 2003). Compounds 42 and
49 exhibited the deprotonated molecular ions at m/z 515 and
typical base peaks at m/z 353. Following the hierarchical key
for the identification of di-caffeoylquinic acids (Clifford et al.,
2003), 42 and 49 were identified as 3,5-dicaffeoylquinic acid and
4,5-dicaffeoylquinic acid, respectively. Finally, compound 55 was
characterized as a tricaffeoylquinic acid due to its [M-H]− ion
at m/z 677 and MS2 and MS3 base peak ions at m/z 515 and
353(Han et al., 2008).
Compound 5, with [M-H]− at m/z 325, suffered the neutral
loss of 162 Da, yielding a fragment ion at m/z 163 (coumaric
acid, due to its typical fragment ion at m/z 119). Hence, it was
identified as coumaric acid-O-hexoside.
Compound 10 was identified as epicatechin considering its
mass spectrum and retention time.
Compound 13 exhibited the deprotonated molecular ion
at m/z 339, and the 179→135 transition, typical from caffeic
acid, was observed in the MS3 mass spectrum. Without further
information, it was tentatively characterized as a caffeic acid
derivative.
Compound 17, with [M-H]− at m/z 367, displayed the base
peak ion at m/z 191 and a secondary fragment ion at m/z
173. According to (Clifford et al., 2003), it was identified as 5-
feruloylquinic acid. Compound 25 was also characterized as a
feruloylquinic acid.
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FIGURE 1 | HPLC-ESI/MSn base peak chromatograms (BPC) of the methanolic extracts from L. czeczottianus and L. nissolia.
Compound 51 exhibited the deprotonated molecular ion at
m/z 359 and presented fragment ions at m/z 197, 179, 161, and
133, which are typical of rosmarinic acid (Liu et al., 2007).
Flavonoids
Most of the observed compounds in the analyzed extracts were
flavonoids. They will be discussed based on their aglycone. The
mass spectra of the glycosides showed the aglycone ions as a
result of the loss of moieties such as hexosyl (162Da), pentosyl
(132Da), or rutinosyl (308Da).
Seven kaempferol derivatives were detected, all of them
showing the aglycone kaempferol at m/z 285 (kaempferol
standard was analyzed to compare its mass spectrum).
Compound 9, with [M-H]− at m/z 755, suffered consecutive
losses of 162 and 308 Da, and was tentatively characterized
as kaempferol-O-hexoside-O-rutinoside. Compounds 21 and
29 exhibited the deprotonated molecular ion at m/z 609 and
suffered two losses of 162 Da, so they were characterized as
kaempferol-O-hexoside-O-hexoside. Compounds 28 and 37
were merely characterized as kaempferol derivatives as the only
fragment ion observed in MS2 corresponded to kaempferol, and
the identity of the attached moieties could not be elucidated.
Compounds 41 and 47 exhibited neutral losses of hexoside
and pentoside moieties, respectively, and were characterized
as kaempferol-O-hexoside and kaempferol-O-pentoside,
respectively.
Four compounds exhibited the aglycone isorhamnetin
(identified by its 315→300 transition) in their fragmentation
patterns. Compound 11, with [M-H]− at m/z 785, suffered
consecutive neutral losses of 162 Da (hexoside) and 308 Da
(rutinoside), yielding isorhamnetin at m/z 315, so it was
characterized as isorhamnetin-O-hexoside-O-rutinoside.
In a similar way, compounds 38 and 53 were
identified as isorhamnetin-O-hexosides, and 44 as
isorhamnetin-O-rutinoside.
Nine apigenin derivatives were tentatively characterized, most
of them C-glycosides. Compound 12 was identified as vicenin-
2 (apigenin-6,8-di-C-hexoside) considering bibliographic data
(Llorent-Martínez et al., 2015). With a similar fragmentation
pattern, compound 26 was also characterized as an apigenin-di-
C-hexoside. The mass spectra of compounds 14, 22, and 27 was
consistent with apigenin-C-hexoside-C-pentoside (Han et al.,
2008). Due to its high abundance, compound 22 was selected
for molecular docking simulations. According to scientific
bibliography (Ferreres et al., 2003), the high relative intensity of
the ion at m/z 503, [M-H-60]−, indicates that the pentose unit
is in position 6. Hence, 22 was characterized as isoschaftoside
(apigenin-6-C-arabinoside-8-C-glucoside). Compound 19, with
[M-H]− at m/z 593, and fragment ions at m/z 473, 431, and
311, was tentatively characterized as apigenin-C-hexoside-O-
hexoside (Zhang et al., 2011). Compound 33 was characterized
as apigenin-8-C-glucoside (vitexin) according to Gouveia and
Castilho (2011). Finally, compounds 43 and 48 exhibited neutral
losses of 308 and 162 Da, respectively, to yield the aglycone
apigenin at m/z 269 (characteristic fragment ion at m/z 225);
therefore, they were identified as apigenin-O-rutinoside and
apigenin-O-hexoside, respectively.
Three luteolin glycosides were detected. Compound 15
exhibited the deprotonated molecular ion at m/z 579, and the
fragment ions at m/z 561, 519, 489, 459, 399, and 369 were
consistent with luteolin-C-hexoside-C-pentoside (Algamdi et al.,
2011). Compound 23 was tentatively characterized as isoorientin
(luteolin-6-C-hexoside) after comparison of its fragmentation
pattern with bibiliographic data (Waridel et al., 2001). Finally,
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TABLE 1 | Characterization of the methanolic extract of aerial parts from L. czeczottianus (S1) and L. nissolia (S2).
No. tR(min) [M-H]m/z m/z (% base peak) Assigned identification Sample References
1 1.1 191 MS2 [191]: 173 (41), 111 (100) Citric acid S1, S2 Flores et al., 2012
2 1.1 377 MS2 [377]: 341 (100), 215 (21)
MS3 [377→341]: 179 (100), 161 (20), 143 (28), 119
(19), 113 (25)
Oligosaccharide derivative S2 —
3 1.5 315 MS2 [315]: 153 (100)
MS3 [315→153]: 109 (95), 108 (100)
Dihydroxybenzoic acid hexoside S1 Engels et al., 2012
4 2.7 353 MS2 [353]: 191 (100), 179 (3), 173 (4) 5-O-caffeoylquinic acid S1, S2 Clifford et al., 2003
5 2.9 325 MS2 [325]: 163 (100)
MS3 [325→163]: 119 (100)
Coumaric acid-O-hexoside S2 —
6 3.1 609 MS2 [609]: 519 (21), 489 (100), 447 (10), 369 (22)
MS3 [609→489]: 471 (9), 399 (42), 369 (100)
Unknown S1 —
7 3.4 865 MS2 [865]: 739 (88), 713 (26), 695 (100), 577 (65),
575 (35), 289 (29), 287 (30)
(Epi)catechin-(epi)catechin-
(epi)catechin
(B-type)
S1 Kajdžanoska et al.,
2010
8 3.6 577 MS2 [577]: 451 (21), 425 (100), 407 (64), 289 (23),
287 (10), 245 (4)
(Epi)catechin-(epi)catechin (B-type) S1 Kajdžanoska et al.,
2010
9 3.9 755 MS2 [755]: 593 (100)
MS3 [755→593]: 285 (100)
MS4[755→593→285]: 257 (100), 229 (47)
Kaempferol-O-hexoside-O-rutinoside S2 —
10 4.5 289 MS2 [289]: 245 (100), 205 (42), 203 (24), 179 (20) Epicatechin S1 Stöggl et al., 2004
11 4.6 785 MS2 [785]: 623 (100)
MS3 [785→623]: 315 (100), 300 (16), 271 (6)
Isorhamnetin
-O-hexoside-O-rutinoside
S2 —
12 4.7 593 MS2 [593]: 575 (10), 503 (29), 473 (100), 383 (38),
353 (99)
MS3 [593→473]: 383 (16), 353 (100)
MS4[593→473→353]: 325 (100), 297 (56)
Vicenin-2 (apigenin
6,8-di-C-hexoside)
S1 Llorent-Martínez
et al., 2015
13 4.9 339 MS2 [339]: 191 (40), 179 (100), 173 (73), 161 (88),
135 (63)
MS3 [339→179]: 135 (100)
Caffeic acid derivative S1 —
14 5.3 563 MS2 [563]: 473 (100), 455 (45), 403 (26), 383 (88),
353 (85), 295 (44)
Apigenin-C-hexoside-C-pentoside S1, S2 Han et al., 2008
15 5.3 579 MS2 [579]: 561 (11), 519 (9), 489 (73), 459 (100),
399 (42), 369 (43)
Luteolin-C-hexoside-C-pentoside S1, S2 Algamdi et al.,
2011
16 5.4 865 MS2 [865]: 739 (48), 713 (28), 695 (100), 577 (44),
575 (13), 407 (27), 289 (10), 287 (23)
(Epi)catechin-(epi)catechin-
(epi)catechin (B-type)
S1 Kajdžanoska et al.,
2010
17 5.7 367 MS2 [367]: 191 (100), 173 (13) 5-feruloylquinic acid S1 Clifford et al., 2003
18 5.8 771 MS2 [771]: 609 (100)
MS3 [771→609]: 301 (100), 300 (18)
MS4[771→609→301]: 271 (56), 255 (41), 179
(100), 151 (80)
Quercetin-O-hexoside-O-rutinoside S2 —
19 5.9 593 MS2 [593]: 593 (100), 473 (29), 431 (19), 311 (27) Apigenin-C-hexoside-O-hexoside S1 Zhang et al., 2011
20 6.1 625 MS2 [625]: 463 (12), 445 (44), 301 (50), 300 (100),
271 (45)
MS3 [625→300]: 179 (100), 151 (41)
Quercetin-O-hexoside-O-hexoside S1, S2 —
(Continued)
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TABLE 1 | Continued
No. tR(min) [M-H]m/z m/z (% base peak) Assigned identification Sample References
21 6.2 609 MS2 [609]: 447 (70), 285 (100)
MS3 [609→285]: 151 (100)
Kaempferol-O-hexoside-O-hexoside S2 —
22 6.5 563 MS2 [563]: 503 (42), 473 (100), 443 (98), 383 (71),
353 (54)
Apigenin-6-C-arabinoside-8-C-
glucoside
(isoschaftoside)
S1, S2 Ferreres et al.,
2003
23 6.5 447 MS2 [447]: 429 (25), 357 (87), 327 (100)
MS3 [447→357]: 339 (66), 297 (100), 285 (15)
MS3 [447→327]: 309 (6), 299 (100), 285 (33)
Luteolin-6-C-hexoside (isoorientin) S1, S2 Waridel et al.,
2001
24 6.6 593 MS2 [593]: 473 (100), 447 (3), 429 (60), 357 (27),
339 (11), 327 (26), 309 (17)
MS3 [593→473]: 327 (100), 298 (35)
2′′-O-Rhamnosyl isoorientin S2 Figueirinha et al.,
2008
25 7.0 367 MS2 [367]: 191 (35), 179 (100), 135 (66) Feruloylquinic acid S1 —
26 7.1 593 MS2 [593]: 503 (16), 473 (100), 383 (55), 353 (43)
MS3 [593→473]: 353 (100)
Apigenin-di-C-hexoside S1 —
27 7.3 563 MS2 [563]: 503 (15), 473 (61), 443 (100), 383 (45),
353 (71)
Apigenin-C-hexoside-C-pentoside S2 Han et al., 2008
28 7.4 739 MS2 [739]: 739 (100), 285 (8), 284 (7)
MS3 [739→284]: 255 (100), 241 (22), 151 (59)
Kaempferol derivative S1 —
29 7.4 609 MS2 [609]: 447 (13), 429 (39), 285 (100), 284 (54)
MS3 [609→285]: 255 (100), 151 (82)
Kaempferol-O-hexoside-O-hexoside S1 —
30 7.4 521 MS2 [521]: 359 (100)
MS3 [521→359]: 344 (100)
Methylated flavonoid-O-hexoside S1 —
31 7.7 755 MS2 [755]: 301 (100)
MS3 [755→301]: 179 (31), 151 (100)
Quercetin derivative S1 —
32 7.7 593 MS2 [593]: 447 (100)
MS3 [593→447]: 301 (100), 300 (23)
MS4[593→447→301]: 179 (100), 151 (30)
Quercetin-O-deoxyhexoside-O-
deoxyhexoside
S2 —
33 8.1 431 MS2 [431]: 341 (13), 311 (100)
MS3 [431→311]: 284 (25), 283 (100)
Vitexin S1, S2 Gouveia and
Castilho, 2011
34 8.1 609 MS2 [609]: 301 (100), 300 (20)
MS3 [609→301]: 179 (100), 151 (27)
Rutin S2 —
35 8.4 463 MS2 [463]: 301 (100), 300 (14)
MS3 [463→301]: 271 (32), 255 (24), 179 (100), 151
(68)
Quercetin-O-hexoside S1, S2 —
36 8.6 607 MS2 [607]: 443 (100), 323 (55)
MS3 [607→443]: 323 (100), 308 (23)
Unknown S2 —
37 8.7 739 MS2 [739]: 285 (100)
MS3 [739→285]: 257 (100), 151 (89)
Kaempferol derivative S1 —
38 9.0 477 MS2 [477]: 315 (100)
MS3 [477→315]: 300 (100)
Isorhamnetin -O-hexoside S2 —
39 9.3 609 MS2 [609]: 609 (100), 301 (28), 300 (38), 271 (12)
MS3 [609→300]: 271 (100), 255 (89), 179 (21)
Quercetin-O-neohesperidoside S2 —
(Continued)
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TABLE 1 | Continued
No. tR(min) [M-H]m/z m/z (% base peak) Assigned identification Sample References
40 9.5 433 MS2 [433]: 301 (77), 300 (100)
MS3 [433→300]: 271 (90), 255 (64), 179 (100), 151
(18)
Quercetin-O-pentoside S1 —
41 9.5 447 MS2 [447]: 284 (100), 255 (16)
MS3 [447→284]: 255 (100), 227 (9)
Kaempferol-O-hexoside S1 —
42 9.8 515 MS2 [515]: 353 (100)
MS3 [515→353]: 191 (100), 179 (92), 173 (22), 135
(19)
3,5-dicaffeoylquinic acid S1 Clifford et al., 2003
43 9.9 577 MS2 [577]: 269 (100)
MS3 [577→269]: 225 (100)
Apigenin-O-rutinoside S2 —
44 9.9 623 MS2 [623]: 315 (100), 300 (16), 271 (10) Isorhamnetin -O-rutinoside S2 —
45 10.2 607 MS2 [607]: 299 (100), 284 (17)
MS3 [607→299]: 284 (100)
Methyl-flavonoid-O-rutinoside S2 —
46 10.4 447 MS2 [447]: 285 (100) Kaempferol/luteolin-O-hexoside S2 —
47 10.5 417 MS2 [417]: 284 (100)
MS3 [417→284]: 255 (100), 227 (5)
Kaempferol-O-pentoside S1 —
48 10.6 431 MS2 [431]: 269 (100)
MS3 [431→269]: 225 (100)
Apigenin-O-hexoside S2 —
49 11.0 515 MS2 [515]: 353 (100), 173 (20)
MS3 [515→353]: 191 (39), 179 (47), 173 (100)
4,5-dicaffeoylquinic acid S1 Clifford et al., 2003
50 11.0 491 MS2 [491]: 329 (100)
MS3 [491→329]: 314 (100), 299 (28)
Compound 56-O-hexoside S2 —
51 11.2 359 MS2 [359]: 197 (21), 179 (34), 161 (100), 133 (10) Rosmarinic acid S1 Liu et al., 2007
52 11.2 461 MS2 [461]: 299 (100)
MS3 [461→299]: 284 (100), 151 (2)
Methyl-flavonoid-O-hexoside S2 —
53 11.6 477 MS2 [477]: 315 (100), 300 (10)
MS3 [477→315]: 300 (100)
Isorhamnetin-O-hexoside S2 —
54 14.4 301 MS2 [301]: 179 (79), 151 (100) Quercetin S1 —
55 15.1 677 MS2 [677]: 515 (100), 353 (27), 335 (7)
MS3 [677→515]: 353 (100), 335 (25), 191 (15), 173
(18)
Tricaffeoylquinic acid S1 Han et al., 2008
56 18.7 329 MS2 [329]: 314 (100)
MS3 [329→314]: 299 (100)
MS4[329→314→299]: 271 (51), 255 (22), 227
(100), 161 (81)
Dimethyl-flavonoid S2 —
57 19.5 327 MS2 [327]: 291 (32), 229 (76), 211 (44), 209 (13),
171 (100)
Oxo-dihydroxy-octadecenoic acid S1, S2 Van Hoyweghen
et al., 2014
58 20.5 327 MS2 [327]: 309 (13), 229 (56), 211 (26), 209 (12),
171 (100)
Oxo-dihydroxy-octadecenoic acid S1, S2 Van Hoyweghen
et al., 2014
59 20.9 391 MS2 [391]: 347 (100), 305 (35), 247 (39), 213 (38) Unknown S1
60 25.0 329 MS2 [329]: 311 (12), 293 (23), 229 (100), 211 (77),
171 (42)
Trihydroxy-octadecenoic acid S1, S2 Van Hoyweghen
et al., 2014
(Continued)
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TABLE 1 | Continued
No. tR(min) [M-H]m/z m/z (% base peak) Assigned identification Sample References
61 25.4 359 MS2 [359]: 344 (100), 329 (22)
MS3 [359→344]: 329 (100) MS4[359→344→329]:
314 (29), 311 (100), 283 (25)
Trimethyl-flavonoid S2 —
62 26.9 971 MS2 [971]: 809 (100), 791 (3), 629 (9), 585 (9)
MS3 [971→809]: 629 (100)
Hex-Hex-HexA-Hederagenin S1 Pollier et al., 2011
63 30.2 941 MS2 [941]: 779 (100), 617 (19)
MS3 [941→779]: 617 (100)
Unknown S1 —
64 31.7 343 MS2 [343]: 328 (100), 313 (18)
MS3 [343→328]: 313 (100) MS4[343→328→313]:
298 (100), 285 (343), 271 (13)
Trimethyl-flavonoid S2 —
65 31.8 691 MS2 [691]: 415 (100), 397 (24), 293 (36)
MS3 [691→415]: 253 (100), 179 (73), 143 (20), 131
(17)
Unknown S1, S2 —
66 33.6 941 MS2 [941]: 923 (100), 879 (31), 795 (8), 751 (7), 733
(22), 615 (6), 525 (12)
MS3 [941→923]: 879 (92), 733 (100), 597 (48)
3-Rha-Gal-GlcA-Soyasapogenol B S1, S2 Pollier et al., 2011
compound 24 was characterized as 2′′-O-rhamnosyl isoorientin
(Figueirinha et al., 2008).
Two compounds presented the deprotonated molecular ion
at m/z 609, and similar fragmentation patterns. Compound 34
was unambiguously identified as rutin after comparison with
an analytical standard, whereas compound 39 was tentatively
identified as quercetin-O-neohesperidoside.
Compound 54, with [M-H]− at m/z 301 and fragment
ions at m/z 179 and 151, was identified as quercetin after
comparison with an analytical standard. Six quercetin derivatives
were detected in the analyzed extracts. The characterization of
compounds 18, 20, 32, 35, and 40 (Table 1) was carried out
considering the observed neutral losses of 162 Da (hexoside), 132
Da (pentoside), 146 Da (deoxyhexoside) and 308 Da (rutinoside),
to yield the aglycone quercetin at m/z 301. Compound 31 was
merely characterized as a quercetin derivative.
Several methylated flavonoids, as aglycones or as glycosides,
were tentatively characterized. Compound 56, with [M-H]− at
m/z 329, suffered two consecutive losses of methyl groups (15
Da), and was characterized as a dimethyl-flavonoid. Compound
50 suffered the neutral loss of 162 Da to yield the aglycone,
which exhibited the same fragmentation pattern than 56, so it was
characterized as its O-hexoside. Compounds 30 and 52 suffered
neutral losses of 162 Da, yielding aglycones that presented the
pattern of methylated flavonoids, so they were characterized as
methyl-flavonoid-O-hexoside. In a similar way, 45 was assigned
to a methyl-flavonoid-O-rutinoside. Finally, compounds 61 and
64 suffered three losses of methyl groups and were characterized
as trimethyl-flavonoids.
Other Compounds
Compound 1, with the deprotonated molecular ion at m/z 191
andMS2 base peak at m/z 111, was identified as citric acid (Flores
et al., 2012).
Compound 2 presented MSn fragment ions at m/z 341,
179, 161, 143, 119, and 113, typical of hexoses (Brudzynski
and Miotto, 2011), and was tentatively characterized as an
oligosaccharide derivative.
Three B-type proanthocyanidins were detected in the extracts
of L. czeczottiaus. Compounds 7 and 16, with [M-H]− at
m/z 865, were characterized as procyanidin trimers of B-
type considering their MS2 fragment ions and consecutive
losses of 288 Da, previously reported in bibliography for
(epi)catechin-(epi)catechin-(epi)catechin (Kajdžanoska et al.,
2010). Compound 8 exhibited its base peak ions at m/z 577, and
fragment ions at m/z 451, 425, 407, 289, and 287, typical from
procyanidin dimers of the type (epi)catechin-(epi)catechin (Ruiz
et al., 2005; Kajdžanoska et al., 2010).
By comparison of their fragmentation patterns and
bibliographic information (Van Hoyweghen et al., 2014),
57 and 58 were characterized as oxo-dihydroxy-octadecenoic
acids, and 60 as trihydroxy-octadecenoic acid.
Finally, two saponins were characterized in the analyzed
extracts. Compounds 62 and 66, with deprotonated molecular
ions at m/z 971 and 941, respectively, were identified after
comparison of their fragmentation patterns (Table 1) with
bibliographic data (Pollier et al., 2011).
Antioxidant Properties
Phenolic compounds are known to serve as multifunctional
bioactive components (anti-oxidant, anti-microbial, anti-
inflammatory and anti-cancer agents). Several studies also
concluded that these components are main contributors on the
antioxidant effects of plant extracts (Shahidi and Ambigaipalan,
2015). In this context, they were selected as target compounds
in the present study. Total phenolic and flavonoid contents
were detected by colorimetric methods, namely Folin-Ciocβlteu
and AlCl3. The results are shown in Table 2. The total phenolic
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content in L. czeczottianus (63.16 mgGAE/g extract) was higher
than in L. nissolia (26.47 mgRE/g extract). However, L. nissolia
(20.97 mgRE/g extract) had higher concentrations of flavonoids
than L. czeczottianus (14.16 mgRE/g extract). Apparently, the
total flavonoids accounted for more than 50% of the total
phenolics in L. nissolia extract. From these results, flavonoids
were thus the major components in L. nissolia extract. This
finding was confirmed also by HPLC-ESI-MSn analysis.
Free radicals trigger a wide variety of chronic and degenerative
diseases, such as Alzheimer’s disease, diabetes mellitus and
cancer. At this point, DPPH and ABTS radicals are widely
used to assess free radical scavenging ability of plant extracts
or synthetic compounds. In these assays, the initial absorbances
(blue for ABTS and purple for DPPH) are decreased by
antioxidants, and these changes are spectrophotometrically
measured (517 nm for DPPH and 734 nm for ABTS). As can
be seen in Table 3, L. czeczottianus was found to exhibit potent
free radical scavenging activities in both DPPH (IC50: 1.42
mg/mL) and ABTS (IC50: 1.80 mg/mL) assays. The observed
remarkable free radical scavenging activity may be explained
by the high level of phenolics in the extracts. This is in
TABLE 2 | Extraction yields, total phenolic and flavonoid contents.
Species Extraction
yields (%)
Total phenolic
content (mg GAE/g
extract)
Total flavonoid
content (mg RE/g
extract)
L. czeczottianus 7.93 63.16 ± 2.41* 14.16 ± 0.40
L. nissolia 14.94 25.47 ± 0.23 20.94 ± 0.78
*Values expressed are means ±S.D. of three parallel measurements. GAE, Gallic acid
equivalent; RE, Rutin equivalent.
accordance with the data published by other authors, indicating
that the higher the total phenolic contents, the better the
free radical scavenging activity (Bannour et al., 2016; Zhang
et al., 2016). Also, some phenolics were reported as effective
hydrogen donors by means of their hydroxyl groups (Sevgi et al.,
2015).
Reducing power is considered as an important antioxidant
feature and it is reflected by the electron-donating ability of
antioxidants. For this purpose, CUPRAC (Cu2+ →Cu+) and
FRAP (Fe3+ →Fe2+) assays were performed. L. czeczottianus
exhibited stronger reducing abilities in both assays as similar
to the free radical scavenging abilities (Table 3). From these
results, the high contents of phenolics in the extracts indicated
that these compounds contribute to the higher reducing abilities.
Similar results were obtained by several researchers, who
reported a strong relationship between total phenolic content and
reducing abilities (Beghlal et al., 2016; Smeriglio et al., 2016).
Phosphomolybdenum assay is based on the reduction of Mo (VI)
to Mo (V) by antioxidants at acidic pH; then, green phosphate-
Mo (V) complex is formed, which has its maximum absorbance
at 695 nm. The phosphomolybdenum activity was observed as
lower for L. czeczottianus (EC50: 1.29 mg/mL) than L. nissolia
(EC50: 0.86 mg/mL). (Table 3). Because phosphomolybdenum
assay is considered as a total antioxidant capacity assay, our
findings for this assay might be attributed also to non-phenolic
antioxidants such as tocopherol or vitamin C. These results
were consistent with other reports (Albayrak et al., 2010; Zengin
et al., 2015). Also, some researchers observed a weak correlation
between total phenolic content and phosphomolybdenum assay
(Nic´iforovic´ et al., 2010; Sarikurkcu et al., 2015).
Transition metals (iron and copper) play an important role
in Fenton and Haber-Weiss reactions, which are main reactions
involved in the production of free radicals. In this sense, the
TABLE 3 | Antioxidant properties [IC50 and EC50 (in CUPRAC, FRAP phosphomolybdenum assays) values, mg/mL].
Species DPPH radical scavenging ABTS radical scavenging CUPRAC FRAP Phosphomolybdenum Metal chelating
L. czeczottianus 1.42 ± 0.04* 1.80 ± 0.01 0.56 ± 0.09 0.51 ± 0.04 1.29 ± 0.03 5>**
L. nissolia 3.19 ± 0.11 5>** 1.11 ± 0.01 1.38 ± 0.11 0.86 ± 0.05 1.14 ± 0.01
Trolox 0.07 ± 0.01 0.24 ± 0.01 0.20 ± 0.01 0.21 ± 0.01 0.41 ± 0.01 nt
EDTA nt nt nt nt nt 0.02 ± 0.001
*Values expressed are means ±S.D. of three parallel measurements. nt: not tested.
**The IC50 values were higher than 5 mg/mL.
TABLE 4 | Enzyme inhibitory properties (IC50 mg/mL).
Species AChE inhibiton BChE inhibition Tyrosinase inhibition α- Amylase inhibition α- Glucosidase inhibition
L. czeczottianus 1.23 ± 0.02* na 2.32 ± 0.10 3.87 ± 0.14 3.54 ± 0.27
L. nissolia 1.22 ± 0.05 5>** na 3.66 ± 0.06 1.01 ± 0.01
Galantamine 0.003 ± 0.001 0.003 ± 0.001 nt nt nt
Kojic acid nt nt 0.13 ± 0.01 nt nt
Acarbose nt nt nt 1.27 ± 0.04 2.19 ± 0.10
*Values expressed are means ±S.D. of three parallel measurements. na: not active; nt: not tested.
**The IC50 value was higher than 5 mg/mL.
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chelating ability of these metals is considered to have a significant
role among the antioxidant mechanisms. The metal chelating
ability of Lathyrus extracts was determined by ferrozine method
and tabulated in Table 3. In contrast to the free radical and
reducing power assays, L. nissolia (IC50: 1.14 mg/mL) exhibited
stronger metal chelating activity compared to L. czeczottianus
(IC50: >5 mg/mL). Thus, the observed activity for L. nissolia
may be caused from non-phenolic chelators, including peptides,
polysaccharides or citric acid. In accordance with our results,
some authors reported that the metal chelating activity of
FIGURE 2 | Schematic representation of the interactions between the best pose found for 5-O-caffeoylquinic acid with (A) AchE, (B) BchE, (C)
α-amylase, (D) α-glucosidase.
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phenolics plays a minor role among antioxidant mechanisms,
and is suggested by several researchers as a secondary antioxidant
mechanism (Rice-Evans et al., 1996; Gursoy et al., 2009; Wang
et al., 2009). To the best of our knowledge, this study is the first
report on the antioxidant properties of these Lathyrus species.
In this direction, the obtained results could be useful to provide
new perspectives on the Lathyrus genus, and its species could
be regarded as potential candidates for developing novel phyto-
pharmaceuticals.
Enzyme Inhibitory Properties
Alzheimer’s disease (AD) and diabetes mellitus (DM) are major
health problems due to the severe increase of their prevalence.
For example, recent reports indicated DM prevalence to be 9%
among adults, and it is supposed to be well above 15% until
2025 (Waltenberger et al., 2016). Today, more than 50 million
people are also affected by AD, and this number is estimated
to increase to 131.5 million people by 2,050 (Prince, 2015).
Therefore, new effective strategies have vital importance in the
FIGURE 3 | Schematic representation of the interactions between the best pose found for vitexin with (A) AchE, (B) BchE, (C) α-amylase, (D)
α-glucosidase.
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treatment of these diseases (Rescigno et al., 2002; Mao et al., 2015;
Zengin et al., 2016). Moreover, key enzyme inhibition theory
is accepted as one of the most efficient strategies to counteract
these diseases (Etxeberria et al., 2012; Murray et al., 2013; Mocan
et al., 2016a,b). At this point, enzyme inhibitory assays are
considered a very useful tool for investigating the biological
properties of herbal extracts or isolated compounds (Bahadori
et al., 2016; Dinparast et al., 2016). Considering the mentioned
aspects, the enzyme inhibitory properties of L. czeczottianus and
L. nissolia toward cholinesterases, α-amylase, α-glucosidase, and
tyrosinase were investigated, and the results are gathered in
Table 4.
The inhibitory effects on cholinesterases of both species are
modest, a higher effect being observed for L. nissolia (IC50:
1.22 mg/mL for AChE). Additionally, L. czeczottianus extract
exhibited a high anti-tyrosinase effect, whereas L. nissolia was
not active toward this enzyme. High anti-tyrosinase effects
and modest inhibitory effects on cholinesterases were already
reported in our previous studies concerning L. aureus and
L. pratensis (Llorent-Martínez et al., 2016). Moreover, higher
inhibitory effects toward α-glucosidase in comparison with α-
amylase were observed in this study, the results being in line
with our previous findings (Llorent-Martínez et al., 2016; Mocan
et al., 2016b). Nonetheless, previous reports indicated that
FIGURE 4 | Schematic representation of the interactions between the best pose found for isoschaftoside with (A) AchE, (B) BchE, (C) α-amylase, (D)
α-glucosidase.
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phenolic compounds have lower α-amylase inhibitory activity
and a stronger inhibition activity against yeast α-glucosidase
(Apostolidis et al., 2011). According to our results, the Lathyrus
species have similar α-amylase inhibition and but L. nissolia
exerted stronger α-glucosidase inhibition as compared to L.
czeczottianus. Also, additional computational studies (molecular
docking) were performed to understand possible interactions
between the target compounds [5-O-CQA (4), isoschaftoside
(22) and vitexin (33)] and tested enzymes as well as to get further
insights into the modulation of biological response.
Molecular Modeling
Enzymatic assays performed on the extract of L. czeczottianus
evidenced a modest inhibition activity to AchE, and strong
tyrosinase, whereas the L. nissolia extracts have shown relevant
inhibition activity for AchE and α-glucosidase. The best and
most representative enzyme-ligand complexes are reported in
Figures 2–8. Among the identified bioactive compounds, vitexin
(33) and 5-O-CQA (4), which were found to be dominant in
both extracts (especially vitexin), and isoschaftoside (22) which
is prevalent in the extract of L. nissolia, were selected for docking
experiments. These compounds have been docked to AchE,
BChE, α-glucosidase, α-amylase and tyrosinase.
The best pose found for 5-O-CQA (4) docked to AchE
(docking score −9.01 Kcal/mol) was stabilized by several
interactions with the residues surrounding the enzymatic pocket
involving Trp84 with one pi–pi stack and His440 with two
hydrogen bonds. The best ranked pose of vitexin (33) to the same
enzyme (score = −8.30 Kcal/mol) interacts with the binding
pocket of the AchE by two hydrogen bonds with Arg289, and
one hydrogen bond with Ser286, Tyr334, Asp72, and Tyr70. The
best pose found for iscoschaftoside (22) docked to AchE was
stabilized by two hydrogen bonds to Ser286, two hydrogen bonds
to Asp285, one hydrogen bond to Tyr121 and a pi–pi stack to
Trp279 (score = −11.05 Kcal/mol). The best pose found for 5-
O-CQA (4) in the enzymatic pocket of BchE was stabilized by
the formation of one hydrogen bond with His438, Gln197 and
Leu286 with a docking score=−9.39 Kcal/mol. The best pose for
isoschaftoside (22) was stabilized by the formation of hydrogen
bond with Glu197, Ser198, Leu286, Ser 287 and a pi–pi stack with
Tyr332 (score=−10.08). The best pose found for vitexin (33) in
the interaction to the enzymatic pocket of BchE was stabilized
by the formation of three hydrogen bonds, respectively, with
Gln197, Asp70, Thr120, and a much lower docking score:−11.24
Kcal/mol. These data are in agreement with the literature data in
which isoschaftoside (22) has shown a high inhibitory activity to
AchE and BChE with IC50 of 0.23 µM and 3.11 µM respectively
(Hung et al., 2015).
5-O-CQA (4) binds to the enzymatic pocket of the α-
amylase by forming a series of hydrogen bonds with Gln63,
Val163, Asp197 residues (docking score = −8.50 Kcal/mol),
whereas vitexin (33) interacted with the enzymatic pocket by
FIGURE 5 | Best pose of 5-O-caffeoylquinic acid with (A) AchE, (B) BchE, (C) α-amylase, (D) α-glucosidase.
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FIGURE 6 | Best pose of vitexin with (A) AchE, (B) BchE, (C) α-amylase, (D) α-glucosidase.
FIGURE 7 | Best pose of isoschaftoside with (A) AchE, (B) BchE, (C) α-amylase, (D) α-glucosidase.
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FIGURE 8 | Best pose of 5-O-caffeoylquinic acid (A) and schematic representation of the interactions between the best pose found for 5-O-caffeoylquinic acid
(B) to tyrosinase.
establishing hydrogen bonds with Tyr62, His201, Glu233, and
Asp300 (docking score = −8.27 Kcal/mol). Isoschaftoside (22)
best pose established several hydrogen bonds to Asp356, Asp330,
Glu233, Asp197, and Trp59, and also two pi–pi stacks to Trp58
and Trp59. Among the three tested substances, it presented
the most favorable docking score (score = −9.69 Kcal/mol) to
this enzyme. Several papers were found in scientific literature
reporting the antidiabetic properties of some medicinal plants
containing isoschaftoside (Song et al., 2012; Khazneh et al., 2016),
so supporting the hypothesis that isoschaftoside may be a good
inhibitor of α-amylase. In a previous study, vitexin (33) proved
to be a potent α-glucosidase inhibitor with a reported EC50
= 0.4 mg/mL, close to that of Acarbose (Yao et al., 2011) and
it was found that its best pose interacted with the enzymatic
pocket of α-glucosidase by forming three hydrogen bonds with
Arg315, Asp215, Arg213, and a pi–pi stack with the aromatic
ring of Phe178 (docking score = −7.29 Kcal/mol). 5-O-CQA
(4) interacted only by forming hydrogen bonds with Asp69,
Trp158, Glu343, and Asp307 (Docking score=−8.83 Kcal/mol);
isoschaftoside (22) interact by forming hydrogen bonds to
Glu411, Asp307, Thr310, Asp242 (score = −7.73 Kcal/mol).
For tyrosinase, the docking of vitexin (33), isoschaftoside (22)
and 5-O-CQA (4) were significantly different. Vitexin (33) and
isoschaftoside (22) were both unable to bind directly to the
copper atoms present in the enzymatic pocket of tyrosinase also
the interactions to the enzymatic pocket are marginal (see Figure
1S in the supporting material); on the contrary, the best pose
found for 5-O-CQA (4) evidenced the ability of the molecule
to coordinate one Cu atom present at the binding pocket of the
enzyme, as depicted in Figure 8. This finding is in full agreement
with our enzymatic assays, and also with the reported inhibitory
activity found for some caffeoylquininic acid derivatives toward
the tyrosinase (Iwai et al., 2004). In conclusion, the docking
experiments performed in this work can explain the literature
data regarding the inhibitory activity of vitexin (33), isoshaftoside
(22) and 5-O-QCA (4), being capable to interact with the residues
present in the binding pocket of the considered enzymes. In
particular, vitexin (33), which has been reported to be efficacious
to control blood glucose in diabetic rats (Choo et al., 2012), is
present in the extracts of both plants and can be addressed as one
of the compounds responsible for the α-glucosidase inhibitory
activity found for both extracts together with isoschaftoside
(22) which has shown a remarkable docking score on alpha-
amylase, whereas 5-O-CQA (4), as demonstrated in the docking
experiments, may efficaciously inhibit the tyrosinase activity by
binding to one Cu atom present in the enzymatic pocket.
Cytotoxicity Assay
Toxicity is a major issue to consider in drug screening or drug
development from natural product derivatives. Some of the
active compounds obtained from these natural products have
biomedical uses such as anti-neoplastic and anti-inflammatory
agents, and the toxicity of these compounds needs to be clarified
by cytotoxicity assays in biological systems. In this study, we
have tested the cytotoxicity of two different Lathyrus species
(L. czeczottianus and L. nissolia) on human embryonic kidney
cells, HEK-293, since these cells are widely used in drug toxicity
studies as kidney may be one of the major target organ of several
toxins (Mantle et al., 2015; Sang et al., 2016). Previous studies
reported the use of HEK-293 cell line for neurobiological research
as well, based on the findings that HEK-293 cells have many
properties in common with neuronal precursors(Shaw et al.,
2002; Thomas and Smart, 2005; Lin et al., 2014). For monitoring
cytotoxicity, we used iCELLigence system, which enables to get
real-time, label-free and non-invasive measurements from living
cells (Bird and Kirstein, 2009; Martinez-Serra et al., 2014). In
recent years, this system has been one of the gold standards in
cell biology research since it measures the effect of the drugs
without any additional treatment on the cells. In addition to
this, RTCA systems have own data analysis software which
calculates IC50 values automatically. In this study, IC50 values
of L. czeczottianus and L. nissolia were determined as 413.19
± 16.3 µg/mL and 1040.83 ± 48.8 µg/mL, respectively, from
three independent experiments in a time and dose dependent
manner after treating cells with six different concentrations of
these two extracts (Figure 9). Furthermore, very high doses were
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FIGURE 9 | Dynamic monitoring of the effects of different doses of L. czeczottianus (A) and L. nissolia (B) extracts on HEK-293 cells by using iCELLigence
real time cell analysis system.
tested, close to IC50 concentrations of the extracts, on HEK-293
cell morphology and almost 50% cellular viability were observed
as seen in middle and right panels compared to control cells
on the left (Figure 10). From these results, the studied extracts
had no cytotoxic activities against HEK-293 cell lines. However,
L. czeczottianus had higher cytotoxic effect with lower value of
IC50 as compared to L. nissolia. In this direction, the observed
remarkable activity for L. nissoliamay be explained by the higher
concentration of flavonoids in the extract. In fact, several authors
reported that some flavonoids exhibited no cytotoxic effects on
various cell lines (Kumar and Pandey, 2013; Sak, 2014). To
the extent of our knowledge, only one previous study has been
conducted on the cytotoxic evaluation of the Lathyrus species (L.
laxiflorus) (Spanou et al., 2010).
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FIGURE 10 | Effects of L. czeczottianus and L. nissolia extracts on HEK-293 cell morphology and viability. Left panel: Control cells. Middle panel: Cells
were treated with 500 µg/mL L. czeczottianus extract. Right panel: Cells were treated with 1000 µg/mL L. nissolia extract.
CONCLUSIONS
Lathyrus species are still an underestimated source of bioactive
compounds, especially flavonoids, being poorly investigated up-
to-date. The present study is the first report on the biological
properties (antioxidant, enzyme inhibitory and cytotoxic effects)
and phytochemical profiles of selected Lathyrus species. On
one hand, L. czeczottianus exhibited remarkable antioxidant
abilities, presenting the highest concentration of phenolics. On
the other hand, L. nissolia had promising inhibitory effects
on the studied enzymes, except for tyrosinase. Additionally,
the extracts exhibited no cytotoxic effects on HEK-293 cell
lines. Molecular docking experiments provided new insights
on some major components (vitexin, isoschaftoside, and 5-O-
caffeoylquininic acid) by studying their interactions with the
enzyme pool, which gave the molecular basis of the biological
response found for these species. According to our results, further
studies on Lathyrus species could open new perspectives for
developing novel health-promoting agents by pharmaceutical
and nutraceutical industries.
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